Athersys stem cell therapy displays power as MS treatment
Athersys said its adult stem therapy for multiple sclerosis has produced lasting neurological improvements in recent animal studies and stopped the disease from progressing.
Inovio preclinical results prove skin delivery potency for DNA vaccines
Inovio Pharmaceuticals says a new minimally invasive skin delivery system for DNA vaccines worked well in animal studies, giving a shot in the arm for potential treatments to prevent HIV and various strains of flu.
Researchers fight colon cancer by targeting tumor-related inflammation
Scientists from around the globe have identified a tantalizing clue that could inform future cancer treatment: blocking inflammation caused by tumors can impair the tumors' development.
Study: Impropriety affects retracted research more than honest mistakes
An alarming number of biomedical and life sciences papers had to be retracted after publication because of misconduct or fraud rather than honest mistakes, researchers conclude. What is driving this? Scientists are fudging their results to advance their careers and labs under pressure from their employers, a New York Times article on the finding explains.
New drug target could halt age-related immune system declines
It's not quite the fountain of youth, but scientists with the Stanford University School of Medicine are zeroing in on a potential protein target that could at least help us age better. By blocking it with a potential new compound, they believe that they can stop age-related immune system declines and many of the diseases that come with this.
UC Davis: Induced pluripotent stem cells resemble cancer cells
Scientists have long seen the potential of using induced pluripotent stem cells (iPSCs) to treat a variety of diseases and injuries. But previous researchers have linked the treatment to an increased cancer risk. And new research by University of California-Davis researchers identifies a possible reason why: That the cells are, in fact, similar to cancer.
Avatar mice up ante for personalized drug treatment research
There's a new trend in research: using mice as avatars, or stand-ins, of sorts--personal guinea pigs for patients seeking the best possible cancer treatment.
CSL's drug candidate reverses Type 2 diabetes in mice and rats
In four trials involving mice and rats, scientists at Australian drug developer CSL didn't just stop Type 2 diabetes from developing, they reversed its progression. If successful in humans, the drug candidate known as 2H10 could represent a major breakthrough, essentially a brand new way to tackle the disease.
Researchers use pancreatic stem cells to boost insulin production
Japanese scientists have found a way to spur transplanted pancreatic islet stem cells to differentiate into insulin-producing pancreatic cells. A mouse flu virus appeared to be the key to making this happen.
The top 20 research institute salaries
Here's a question: As the nation's leading, independent nonprofit life sciences research institutes pursue the quest for cures and answers to the major medical challenges of our time, how high a salary should be paid to the person in charge?
Check out the full top 20 list >>
Top 20 Research Institute Salaries
Here's a question: As the nation's leading, independent nonprofit life sciences research institutes pursue the quest for cures and answers to the major medical challenges of our time, how high a salary should be paid to the person in charge?
Bristol-Myers, Vanderbilt U. forge Parkinson's drug development deal
Vanderbilt University will team up with Bristol-Myers Squibb ($BMY) to identify new Parkinson's disease treatments and guide them from the lab to the clinic, and ultimately, the marketplace.
Roche, AstraZeneca lung cancer Rx beat Alzheimer's in fruit flies and mice
Two lung cancer drugs developed by Roche and AstraZeneca, along with other related synthetic compounds, successfully reversed Alzheimer's-like memory loss in fruit fly and mouse trials. The finding comes from research that spanned the globe, involving neuroscientists in the U.S. and China.
Constellation gains $7.5M to advance preclinical blood cancer drug
Drug developer Constellation Pharmaceuticals has found crucial funding support to advance a potential treatment for blood, bone marrow or lymph node-related cancers from preclinical testing to human trials.
Roswell Park researchers spot versatile cancer treatment
A cancer drug appears to slap down tumor cells that become resistant to treatment, taking away their ability to live and multiply, researchers at Roswell Park Cancer Institute in Buffalo, NY, have discovered.
Natural killer cells may be key to lung cancer susceptibility
When it comes to getting lung cancer, natural killer cells may determine how susceptible you are to the disease, scientists at the Washington University School of Medicine in St. Louis discovered.
Bad breath bacteria could point to pancreatic cancer
Bad breath bacteria may indicate a significant risk for pancreatic cancer, according to researchers from the Forsyth Institute, Harvard University and Brown University.
Mayo Clinic spies enzyme that destroys brain-clogging Alzheimer's protein
Mayo Clinic scientists believe they've found an enzyme that could defeat Alzheimer's disease by destroying the brain-clogging protein that is a hallmark of the condition as it advances.
Drug combo packs punch fighting rare form of melanoma in mice
A new drug combination seems to work in mouse trials against a particular form of melanoma that lacks an otherwise viable treatment. Credit MD Anderson Cancer Center at The University of Texas, along with colleagues at Harvard Medical School and Boston University, for coming up with the breakthrough.
UMass sensor array 'smelled' metastatic cancer cells in preclinical study
Gold nanoparticles and proteins together formed a potent new diagnostic that identified microscopic levels of metastatic tissues in a preclinical study involving mice. The combination essentially "smelled" the different cancer types.
